Literature DB >> 23958402

In vitro susceptibility of Conidiobolus lamprauges recovered from sheep to antifungal agents.

Juliana Simoni Moraes Tondolo1, Érico Silva de Loreto, Valéria Dutra, Luciano Nakazato, Daphine Ariadne Jesus de Paula, Régis Adriel Zanette, Sydney Hartz Alves, Janio Morais Santurio.   

Abstract

Data regarding the susceptibility of Conidiobolus lamprauges is limited and there is no consensus about the optimal treatment for infections caused by Conidiobolus spp. In this context, the objective of this study was to evaluate the in vitro susceptibility of six C. lamprauges strains isolated from sheep conidiobolomycosis to amphotericin B, ketoconazole, fluconazole, itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, flucytosine, and terbinafine using the CLSI M38-A2 microdilution technique. Terbinafine was the most active (MIC range <0.06-0.5 μg/mL). Resistance or reduced susceptibility was observed for amphotericin B and azole and echinocandin antifungals. Additional studies are necessary to determine the therapeutic potential of terbinafine as monotherapy or in combination therapy with other antifungals.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conidiobolomycosis; Susceptibility testing; Terbinafine

Mesh:

Substances:

Year:  2013        PMID: 23958402     DOI: 10.1016/j.vetmic.2013.07.024

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  2 in total

1.  In Vitro Assessment of Antifungal Drugs and Sulfamethoxazole-Trimethoprim against Clinical Isolates of Conidiobolus lamprauges.

Authors:  Juliana S M Tondolo; Erico S Loreto; Francielli P K Jesus; Valéria Dutra; Luciano Nakazato; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 2.  Human Fungal Pathogens of Mucorales and Entomophthorales.

Authors:  Leonel Mendoza; Raquel Vilela; Kerstin Voelz; Ashraf S Ibrahim; Kerstin Voigt; Soo Chan Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.